An interventional study of SMS text messaging - interactive check-in and SMS text messaging - inactive control in Psychotic Disorders, sponsored by Centre for Addiction and Mental Health. Completed at 1 site in Canada. Open to participants aged 16 Years to 29 Years. Per ClinicalTrials.gov, last updated 2020-05-08.
Sponsored by Centre for Addiction and Mental Health · Not applicable, Interventional, and Treatment
Engagement with clinical services for youth with early psychosis represents a significant challenge, with up to 40% of patients dropping out of treatment in the first year. This has been linked to worse illness outcomes and represents a significant barrier to recovery for these patients. This study aims to evaluate the efficacy of short message service (SMS) as a means of improving clinical engagement in early-episode psychosis populations by bridging contact between appointments with weekly check-ins/reminders. These weekly check-ins during the first year of treatment will serve as an additional opportunity to reach out to patients and give them a chance to do the same with their care teams, with patient responses triggering clinician follow-up if necessary.
1,655 studies on the registry are indexed under Psychotic Disorders; 298 are open to participants now.
This study's enrollment of 61 is below the median of 68 across 1,358 interventional studies indexed under Psychotic Disorders.
Browse Psychotic Disorders studies →Centre for Addiction and Mental Health is the lead sponsor of 339 studies on the registry; 51 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Weekly interactive SMS text messaging check-ins.
Behavioral: SMS text messaging - interactive check-in
Weekly minimally interactive SMS text messages.
Behavioral: SMS text messaging - inactive control
Interactive SMS text message check-ins delivered once weekly to participants.
Minimally interactive SMS text message delivered once weekly to participants.
Service Engagement Scale (SES)
Clinician-rated treatment engagement and adherence (minimum score = 0, maximum score = 42, higher score indicates worse service engagement)
Time frame: 9 months
Appointment Attendance
Percentage of attended clinic appointments
Time frame: 9 months
Emergency Department Visits
Number of emergency department visits
Time frame: 9 months
Hospitalizations
Number of hospitalizations
Time frame: 9 months
Social Functioning Scale (SFS)
Self-report measure of social functioning (minimum score = 0, maximum score = 247, higher score indicates better functioning)
Time frame: 9 months
Personal and Social Performance Scale (PSP)
Interview-rated measure of global functioning (minimum score = 1, maximum score = 100, higher score indicates better functioning)
Time frame: 9 months
Quality of Life Enjoyment and Satisfaction Questionnaire (Q-LESQ-18)
Self-reported measure of subjective quality of life (minimum score = 1, maximum score = 5, higher score indicates better quality of life)
Time frame: 9 months
Clinical Global Impression (CGI)
Interview-based global rating of illness severity (minimum score = 1, maximum score = 7, higher score indicates worse illness severity)
Time frame: 9 months
Brief Psychiatric Rating Scale (BPRS)
Interview-based measure of the severity of psychiatric symptoms (minimum score = 24, maximum score = 168, higher score indicates higher severity of symptoms)
Time frame: 9 months
Scale for the Assessment of Negative Symptoms (SANS)
Interview-based measure of the severity of negative symptoms (minimum score = 0, maximum score = 110, higher score indicates higher severity of symptoms)
Time frame: 9 months
Apathy Evaluation Scale (AES)
Interview-rated measure of the severity of motivation deficits (minimum score = 18, maximum score = 72, higher score indicates worse motivation deficits)
Time frame: 9 months
Brief Cognitive Assessment Tool for Schizophrenia (B-CATS)
Rater-administered measure of cognitive functioning (scores indicate standardized Z-scores with no pre-defined minimum or maximum score, higher score indicates better cognitive functioning)
Time frame: 9 months
Drug Attitude Inventory (DAI-10)
Self-reported measure of medication adherence (minimum score = -10, maximum score = + 10, higher score indicates better adherence)
Time frame: 9 months
Scale To Assess Therapeutic Relationships - Patient Version (STAR-P)
Self-reported measure of the clinician-patient therapeutic relationship (minimum score = 0, maximum score = 48, higher score indicates better therapeutic relationship)
Time frame: 9 months
Plan to share: No
This study is completed, as verified in May 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Centre for Addiction and Mental Health →